tradingkey.logo
搜尋

FibroGen Ord Shs

KYNB
添加自選
7.250USD
-0.030-0.41%
收盤 09-23 16:00美東
29.36M總市值
0.18本益比TTM

關於 公司

FibroGen Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

FibroGen Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
1.36K
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
1.36K
--
Dr. Maykin Ho, Ph.D.
Dr. Maykin Ho, Ph.D.
Independent Director
Independent Director
1.26K
--
Dr. Maykin Ho, Ph.D.
Dr. Maykin Ho, Ph.D.
Independent Director
Independent Director
1.26K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%

常見問題

FibroGen Ord Shs的前五大股東是誰?

FibroGen Ord Shs的前五大股東如下:Mr. James A. (Jim) Schoeneck

有多少機構持有FibroGen Ord Shs(KYNB)的股份?

截至2026Q1,共有184家機構持有FibroGen Ord Shs的股份,合計持有的股份價值約為1.35M,占公司總股份的33.36% 。與2025Q4相比,機構持股有所增加,增幅為-396059.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有